Actavis - actavis.com
General Information:
Latest News:
Actavis Launches Generic Viagra® in Europe as Patents Expire 24 Jun 2013 | 12:01 pm
Actavis, Inc. (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched Sildenafil Actavis 25 mg, 50 mg and 100 mg tablets in 11 major Western-European marke...
Actavis Launches Zoledronic Acid on Patent Expiry In 14 European Countries 30 May 2013 | 12:26 am
Actavis, Inc. (NYSE: ACT) has launched Zoledronic Acid Actavis 4mg/5ml concentrate for solution for infusion in 14 European markets on market formation. The Actavis product was first to market in Germ...
Actavis launches Montelukast as patents expire in Europe 6 Mar 2013 | 10:00 am
Zug, Switzerland, March 6, 2013 -- Actavis, Inc. (NYSE: ACT) has launched Montelukast tablets immediately after patent expiry in Denmark, France, Germany, Ireland, Italy, the Netherlands, Slovenia, Sp...
Redirect to NewsRoom 16 Jan 2013 | 05:05 pm
Not real news
Watson Confirms Velcade® Patent Challenge 28 Dec 2012 | 07:22 pm
Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that Actavis, Inc., which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug A...
Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top 20 Dec 2012 | 07:33 pm
Watson Pharmaceuticals announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2013 Goldman Sachs Healthc...
Actavis Launches Generic Pariet® in Europe as Patent Expires 16 Nov 2012 | 04:29 pm
Actavis today announced the launch of Rabeprazole in Germany, France, Spain, the Netherlands and UK immediately after the patents expired on 12-13 November. The product will be launched in Italy short...
Watson to Present at the 2012 Piper Jaffray Health Care Conference 14 Nov 2012 | 07:39 pm
Watson Pharmaceuticals announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2012 Piper Jaffray Health ...
Watson to Present at the Jefferies 2012 Global Healthcare Conference 7 Nov 2012 | 02:21 am
Watson Pharmaceuticals announced today that Siggi Olafsson, Watson's President, Global Generics, will provide an overview and update of the Company's business at the Jefferies 2012 Global Healthcare C...
Watson to Present at the 2012 Annual Credit Suisse Healthcare Conference 6 Nov 2012 | 07:05 pm
Watson Pharmaceuticals announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2012 Annual Credit Suisse ...
